If something hasnt gone through the TGAs assessment process, nobody, not the person selling it, not the person buying it, can reliably tell you whats in it, whether it works, or whether its safe. The TGA has listed safety considerations for healthcare professionals to advise patients who are using unapproved peptide products
However, dosing regimens, administration routes, and treatment durations vary considerably across these studies, making direct comparisons challenging (Pickart & Margolina, 2018)
Jan 18, 2026 You've done the research
tirzepatide is a dual agonist (GIP/GLP-1) Peak weight loss : Retatrutide showed 28.7% at 68 weeks (Phase 3 TRIUMPH-4) and 24.2% at 48 weeks (Phase 2) vs tirzepatide 20.9% (Phase 3) Liver fat : Retatrutide's glucagon agonism provides pronounced hepatic fat reduction (up to 82%) Regulatory status : Tirzepatide is FDA-approved
The procedure is quick, taking only a few seconds, and most patients report minimal discomfortsimilar to other intramuscular injections such as vaccines
When levels are low, signals do not travel as efficiently, which can lead to these strange sensations
